In summary, RioGin's double binding technology:

  • Two reversible tags to hSA
  • Eliminates kidney filtration problem
    • Increases half-life
    • Weekly dosing regimen possible
  • Absolute control of active concentration
    • Reduces side effects
    • Improves patient complience
  • New intellectual property
    • New composition of matter
  • Reduces costs due to lower dosage requirements
  • Low volume micro needle delivery